More on BCTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (10/26/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BriaCell Therapeutics (NQ:BCTX)
Delayed: 3.47 +0.04 (1.17%)
Prev. Close $3.43  
Open$3.49 
52 Wk High$ 
52 Wk Low$ 
Day High$3.60 
Day Low$3.44 
P/E N/A  
EPS$ 
Volume50,376 

Friends, Peers and Foes (?): BCT, BCTXW, BCTXZ BCTXL (more...)

Oct 23, 2026 07:30 AM BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Oct 6, 2026 07:30 AM BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Sep 14, 2026 07:30 AM BriaCell's Phase 3 breast cancer study clears seventh DSMB review
Sep 14, 2026 07:30 AM Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
Sep 11, 2026 08:45 AM Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
Sep 8, 2026 07:30 AM BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial
Sep 8, 2026 07:30 AM BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
Aug 24, 2026 07:35 AM BriaCell advances melanoma vaccine candidate to genetic engineering milestone
Jun 26, 2026 04:06 PM Form 8-K BriaCell Therapeutics For: Jun 26
Jun 9, 2026 04:06 PM Form 10-Q BriaCell Therapeutics For: Apr 30
View All Articles

Entities mentioned with BCTX

View All Entities